MFX
  • Home
  • Technology
  • Data
  • People
  • News
  • Jobs
  • Contact
Select Page

News

Press Releases

MFX appoints Dr. Katy Newton as Chief Scientific Officer to drive innovation for cell-based therapies

18 March 2025

MFX, Tolemy Bio and Aminoacids.com Partner to Deliver Model-Driven Media Optimization for Cell and Gene Therapies

05 December 2024

MFX secures Innovate UK award to advance high throughput stackable bioreactor platform for Cell and Gene Therapies

19 December 2023

View all press releases

Blog

99 problems in cell research – manual handling is number one

Read more

New technologies, old methods- Why 99% of cell culture vessels will never scale

Read more

How to ensure a consistent cell expansion process? Don’t start at the end

Read more

Footprint size matters in cell and gene therapy manufacturing

Read more

Is innovation in automation enough to drive cell therapy manufacturing optimization?

Read more

Why successful cell therapy processes need to scale both ways

Read more

Scale up, look sharp – why analytics in large-scale cell therapy manufacture is so difficult

Read more

Microfluidics- the perfect meeting-place for viruses and cells

Read more

Make your cells feel at home with microfluidics

Read more

How do you solve a problem like scaling up microfluidics?

Read more

Making cell therapies comPATible with large scale manufacturing

Read more

Data and Digitization – The key to better biology and more effective therapies

Read more
View all blogs

Newsfeed

The Cyto Engine and MFX Bioreactors are Prototypes in Development. This Information Is For Research & Development Use Only. Not For Manufacturing, Diagnostic, Clinical Or Therapeutic Use

MFX (microfluidx Ltd) 2024 © All rights reserved

MFX (microfluidx) is registered in England and Wales No. 11643516

  • Follow
  • Follow

Privacy Policy

Cookie Policy

Sign up for the latest updates on the Cyto Engine and insights into CGT manufacturing

Success! Look out for the latest from MFX in your inbox

Sign up